Works by Dreyling, Martin
Results: 139
Antikörpertherapie maligner Lymphome.
- Published in:
- Medizinische Klinik (Urban & Vogel), 2005, v. 100, n. 1, p. 14, doi. 10.1007/s00063-005-1115-0
- By:
- Publication type:
- Article
Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 23, p. 1799, doi. 10.1093/jnci/djr418
- By:
- Publication type:
- Article
Response: Re: Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 18, p. 1289, doi. 10.1093/jnci/djp257
- By:
- Publication type:
- Article
Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 4, p. 248, doi. 10.1093/jnci/djn478
- By:
- Publication type:
- Article
Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 9, p. 706, doi. 10.1093/jnci/djk152
- By:
- Publication type:
- Article
Rationale for Consolidation to Improve Progression-Free Survival in Patients with Non-Hodgkin's Lymphoma: A Review of the Evidence.
- Published in:
- Oncologist, 2009, v. 14, p. 17, doi. 10.1634/theoncologist.2009-S2-17
- By:
- Publication type:
- Article
Harnessing the Energy: Development of Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma.
- Published in:
- Oncologist, 2009, v. 14, p. 4, doi. 10.1634/theoncologist.2009-S2-4
- By:
- Publication type:
- Article
Rationale for Consolidation to Improve Progression-Free Survival in Patients with Non-Hodgkin's Lymphoma: A Review of the Evidence.
- Published in:
- Oncologist, 2009, p. 17, doi. 10.1634/theoncologist.2009-S2-17
- By:
- Publication type:
- Article
Harnessing the Energy: Development of Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma.
- Published in:
- Oncologist, 2009, p. 4, doi. 10.1634/theoncologist.2009-S2-4
- By:
- Publication type:
- Article
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 474, doi. 10.1016/j.clml.2021.12.018
- By:
- Publication type:
- Article
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e886, doi. 10.1016/j.clml.2021.06.021
- By:
- Publication type:
- Article
IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S403, doi. 10.1016/S2152-2650(21)01911-X
- By:
- Publication type:
- Article
Poster: IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01539-1
- By:
- Publication type:
- Article
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting mTOR/PI3K in Primary CNS Lymphoma (PCNSL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S107, doi. 10.1016/j.clml.2016.07.155
- By:
- Publication type:
- Article
Treatment of indolent lymphoma in Germany -- results of a representative population-based survey.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Treatment of Indolent Lymphoma in Germany - Results of a Representative Population-Based Survey.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 204, doi. 10.1016/j.clml.2011.03.001
- By:
- Publication type:
- Article
Management of Mantle Cell Lymphoma: Key Challenges and Next Steps.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 5, p. 336, doi. 10.3816/CLML.2010.n.066
- By:
- Publication type:
- Article
Optimal Use of Bendamustine in Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphomas, and Multiple Myeloma: Treatment Recommendations From an International Consensus Panel.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 1, p. 21, doi. 10.3816/CLML.2010.n.002
- By:
- Publication type:
- Article
3'UTR mediated regulation of the cyclin D1 proto-oncogene.
- Published in:
- Cell Cycle, 2009, v. 8, n. 21, p. 3592, doi. 10.4161/cc.8.21.9993
- By:
- Publication type:
- Article
Current management of follicular lymphomas.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 2, p. 191, doi. 10.1111/j.1365-2141.2006.06378.x
- By:
- Publication type:
- Article
Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 1, p. 3, doi. 10.1111/j.1365-2141.2006.05975.x
- By:
- Publication type:
- Article
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 1, p. 29, doi. 10.1111/j.1365-2141.2005.05716.x
- By:
- Publication type:
- Article
CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 1995, v. 91, n. 4, p. 865, doi. 10.1111/j.1365-2141.1995.tb05402.x
- By:
- Publication type:
- Article
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 7, p. 2373, doi. 10.1007/s00277-024-05689-w
- By:
- Publication type:
- Article
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2791, doi. 10.1007/s00277-023-05385-1
- By:
- Publication type:
- Article
Altered treatment of chronic lymphocytic leukemia in Germany during the last decade.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Temsirolimus acts as additive with bendamustine in aggressive lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 5, p. 803, doi. 10.1007/s00277-013-1976-x
- By:
- Publication type:
- Article
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 847, doi. 10.1007/s00277-011-1377-y
- By:
- Publication type:
- Article
Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.
- Published in:
- Histopathology, 2011, v. 58, n. 4, p. 586, doi. 10.1111/j.1365-2559.2011.03779.x
- By:
- Publication type:
- Article
The expression of activation induced cytidine deaminase in follicular lymphoma is independent of prognosis and stage.
- Published in:
- 2009
- By:
- Publication type:
- Letter
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma.
- Published in:
- Electrophoresis, 2009, v. 30, n. 6, p. 974, doi. 10.1002/elps.200800508
- By:
- Publication type:
- Article
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomasThe authors dedicate this paper to Reza Parwaresch, who served as a reference pathologist for the German Low‐Grade Lymphoma Study Group (GLSG) over many years and who died unexpectedly in November 2005.: Results of a prospective randomized trial of the German Low‐Grade Lymphoma Study Group
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1014
- By:
- Publication type:
- Article
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphoma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
The role of fludarabine in the treatment of follicular and mantle cell lymphoma.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 5, p. 883
- By:
- Publication type:
- Article
Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia – an updated meta‐analysis.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 234, doi. 10.1111/bjh.15901
- By:
- Publication type:
- Article
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 558, doi. 10.1111/bjh.15690
- By:
- Publication type:
- Article
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 616, doi. 10.1111/bjh.15519
- By:
- Publication type:
- Article
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 430, doi. 10.1111/bjh.14870
- By:
- Publication type:
- Article
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 410, doi. 10.1111/bjh.14860
- By:
- Publication type:
- Article
Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 4, p. 606, doi. 10.1111/bjh.13132
- By:
- Publication type:
- Article
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 91, doi. 10.1111/bjh.12853
- By:
- Publication type:
- Article
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 5, p. 565, doi. 10.1111/j.1365-2141.2010.08298.x
- By:
- Publication type:
- Article
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 3, p. 317, doi. 10.1111/j.1365-2141.2008.07443.x
- By:
- Publication type:
- Article
Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 858, doi. 10.1002/hon.3194
- By:
- Publication type:
- Article
Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 36, doi. 10.1002/hon.3149
- By:
- Publication type:
- Article
Mantle cell lymphoma-Advances in molecular biology, prognostication and treatment approaches.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Structured reporting adds clinical value in primary CT staging of diffuse large B-cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article